MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 141 to 160 of 166,322 approvalsPage 8 of 8317

Potassium Chloride Oral Solution

Approval Number: 国药准字H20254245
Registration: May 27, 2025

Ibuprofen Suspension Drops

Approval Number: 国药准字H20254258
Registration: May 27, 2025

Deutenzalutamide Soft Capsules

Approval Number: 国药准字H20250029
Registration: May 27, 2025

Mirtazapine Tablets

Approval Number: 国药准字H20254247
Registration: May 27, 2025

Tadalafil Tablets

Approval Number: 国药准字H20254296
Registration: May 27, 2025

Potassium Chloride Granules

Approval Number: 国药准字H20254319
Registration: May 27, 2025

Dobutamine Hydrochloride Injection

Approval Number: 国药准字H20254389
Registration: May 27, 2025

Bisoprolol Fumarate and Amlodipine Besilate Tablets

Approval Number: 国药准字H20254304
Registration: May 27, 2025

Epirubicin Hydrochloride for Injection

Approval Number: 国药准字H20254277
Registration: May 27, 2025

Ceftizoxime Sodium for Injection

Approval Number: 国药准字H20254291
Registration: May 27, 2025

Oxygen

Approval Number: 国药准字H20254402
Registration: May 27, 2025

Oxygen

Approval Number: 国药准字H20254309
Registration: May 27, 2025

Albipagrastim alfa for Injection

Approval Number: 国药准字S20250021
Registration: May 27, 2025

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number: 国药准字H20254275
Registration: May 27, 2025

Imidapril Hydrochloride Tablets

Approval Number: 国药准字H20254399
Registration: May 27, 2025

Telmisartan and Amlodipine Tablets (Ⅱ)

Approval Number: 国药准字H20254352
Registration: May 27, 2025

Iguratimod Tablets

Approval Number: 国药准字H20254383
Registration: May 27, 2025

Ropivacaine Hydrochloride Injection

Approval Number: 国药准字H20254307
Registration: May 27, 2025

Levocetirizine Dihydrochloride Oral Solution

Approval Number: 国药准字H20254395
Registration: May 27, 2025

Nitroglycerin Injection

Approval Number: 国药准字H20254310
Registration: May 27, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.